Increasing anti-S antibody testing: a quality improvement initiative with evolving COVID-19 guidelines

Author:

Alam Ali MORCID,Lester Rebecca,Hoyle Marie-Claire,Fletcher Tom E,Hine Paul

Abstract

BackgroundCOVID-19 management guidelines are constantly evolving, making them difficult to implement practically. Ronapreve was a neutralising monoclonal antibody introduced into UK COVID-19 guidelines in 2021. It reduces mortality in seronegative patients infected with non-omicron variants. Antibody testing on admission is therefore vital in ensuring patients could be considered for Ronapreve as inpatients.Local problemWe found that on our COVID-19 ward, 31.4% of patients were not having anti-S tests despite fulfilling the other criteria to be eligible for Ronapreve. This was identified as an important target to improve; by not requesting anti-S tests, we were forgoing the opportunity to use an intervention that could improve outcomes.MethodsWe analysed patient records for patients with COVID-19 admitted to our ward over 4 months to observe if awareness of the need to request anti-S increased through conducting plan–do–study–act (PDSA) cycles.InterventionsOur first intervention was an multidisciplinary team (MDT) discussion at our departmental audit meeting highlighting our baseline findings and the importance of anti-S requesting. Our second intervention was to hang printed posters in both the doctors’ room and the ward as a visual reminder to staff. Our final intervention was trust-wide communications of updated local COVID-19 guidance that included instructions for anti-S requesting on admission.ResultsOur baseline data showed that only 68.6% of patients with symptomatic COVID-19 were having anti-S antibody tests requested. This increased to 95.0% following our three interventions. There was also a reduction in the amount of anti-S requests being ‘added on’, from 57.1% to 15.8%.ConclusionsCOVID-19 guidelines are constantly evolving and require interventions that can be quickly and easily implemented to improve adherence. Sustained reminders through different approaches allowed a continued increase in requesting. This agrees with research that suggests a mixture of educational sessions and visual reminders of guidelines increase their application in clinical practice.

Funder

University of Liverpool

Publisher

BMJ

Subject

Public Health, Environmental and Occupational Health,Health Policy,Leadership and Management

Reference13 articles.

1. United Kingdom Government . Patients admitted to hospital. Available: https://coronavirus.data.gov.uk/details/healthcare?areaType=overview&areaName=United%20Kingdom#card-patients_admitted_to_hospital [Accessed 21 Feb 2022].

2. Randomised evaluation of COVID-19 therapy. results. Available: https://www.recoverytrial.net/results [Accessed 21 Feb 2022].

3. Medicines & Healthcare products Regulatory Agency . Summary of product characteristics for Ronapreve. Available: https://www.gov.uk/government/publications/regulatory-approval-of-ronapreve/summary-of-product-characteristics-for-ronapreve [Accessed 21 Feb 2022].

4. Department of Health & Social Care . Antibody testing for SARS-CoV-2: key information. Available: https://www.gov.uk/government/publications/antibody-testing-for-sars-cov-2-key-information/antibody-testing-for-sars-cov-2-information-for-general-practitioners [Accessed 21 Feb 2022].

5. Randomised Evaluation of COVID-19 Therapy (RECOVERY) . RECOVERY trial finds Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients who have not mounted their own immune response. Available: https://www.recoverytrial.net/news/recovery-trial-finds-regeneron2019s-monoclonal-antibody-combination-reduces-deaths-for-hospitalised-covid-19-patients-who-have-not-mounted-their-own-immune-response-1 [Accessed 21 Feb 2022].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3